Advertisement

Gilead Sciences (GILD)

Stock Market Today 9/14/20: Big Deal! Stocks Solidly in the Black on 'M&A Monday'
Markets

Stock Market Today 9/14/20: Big Deal! Stocks Solidly in the Black on 'M&A Monday'

Big dealmaking from Nvidia (NVDA) and Gilead Sciences (GILD), as well as renewed COVID vaccine hopes, sent a jolt into stocks Monday.
September 14, 2020
Closing Bell 7/13/20: This Is Your Market on (Coronavirus) Drugs
Markets

Closing Bell 7/13/20: This Is Your Market on (Coronavirus) Drugs

A rapid rally to start the week, sparked by encouraging vaccine news from Pfizer and BioNTech, collapsed in the afternoon.
July 13, 2020
Closing Bell 7/10/20: Gilead Gives Stocks a Booster Shot
Markets

Closing Bell 7/10/20: Gilead Gives Stocks a Booster Shot

Stocks rallied out of negative territory Friday after Gilead announced that remdesivir helped reduce COVID-19 mortality risk in a clinical trial.
July 10, 2020
Gilead Sciences' (GILD) Remdesivir Sparks Market Hope With Trial Success
investing

Gilead Sciences' (GILD) Remdesivir Sparks Market Hope With Trial Success

Gilead's COVID-19 treatment shows efficacy in Phase 3 trial, NIAID study
April 29, 2020
Advertisement
How to Survive the Economic Fallout from COVID-19
investing

How to Survive the Economic Fallout from COVID-19

The bull market and economic expansion are over. Here's what to do now.
March 26, 2020

Subscribe to Kiplinger's Personal Finance

Be a smarter, better informed investor.
5 Undervalued Stocks With Free Cash Flow to Burn
stocks

5 Undervalued Stocks With Free Cash Flow to Burn

Look beyond the P/E. These five firms are inexpensive based on free cash flow.
September 22, 2017
Why I'm Hanging On to a Loser
investing

Why I'm Hanging On to a Loser

Gilead is way down from when I bought it, but it is flush with cash and has dozens of promising medications in its pipeline.
August 24, 2017
Advertisement
Advertisement
Can This Fallen Biotech Be Revived?
investing

Can This Fallen Biotech Be Revived?

I've been sorely tempted to sell my Gilead shares. But now that they're cheaper, maybe I should buy more.
April 12, 2017
This Stumbling Biotech Stock Still Has a Lot of Promise
investing

This Stumbling Biotech Stock Still Has a Lot of Promise

Gilead Sciences' robust product pipeline should turn things around.
January 3, 2017
3 Bargain Stocks to Beat the Market
stocks

3 Bargain Stocks to Beat the Market

The Value Line Investment Survey sees a strong year ahead for these picks.
June 2, 2015
Promising Bargains in Biotech Stocks
investing

Promising Bargains in Biotech Stocks

What I like about BioDelivery Sciences is not so much that there are many ways to win as that there are almost no ways to lose.
October 6, 2014